Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01827111
Title Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Ipilimumab + Nab-paclitaxel

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.